Sergiu Catrina
Karolinska institute, Centre for diabetes · Karolinska University Hospital · Karolinska Institutet
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sergiu Catrina as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05810311 · The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyRegion Stockholm · not yet recruiting · Diabetes Complications, Diabetes; Nephropathy (Manifestation) · principal investigator
- Ph2NCT03137966 · Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot UlcersKarolinska University Hospital · unknown · Diabetic Foot Ulcer · principal investigator
- Ph2NCT03085771 · Desferal Administration to Improve the Impaired Reaction to Hypoxia in DiabetesKarolinska University Hospital · unknown · Diabetes Mellitus, Type 1 · principal investigator
- Ph2/Ph3NCT01002209 · Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular SurgeryKarolinska Institutet · withdrawn · Diabetes, Peripheral Arterial Disease, Arterial Occlusive Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:55 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP.J Clin Invest · 202317 citationsRCR 2.0
- 11 citationsRCR 0.8
- Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial.Pulm Pharmacol Ther · 202410 citationsRCR 2.2
- Effect of rosiglitazone on early-morning plasma cortisol levels.Neuro Endocrinol Lett · 20056 citationsRCR 0.1
- Desmopressin increases IGF-binding protein-1 in humans.Eur J Endocrinol · 20086 citationsRCR 0.2
- Effect of Isocaloric Meals on Postprandial Glycemic and Metabolic Markers in Type 1 Diabetes-A Randomized Crossover Trial.Nutrients · 20236 citationsRCR 0.8
- Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study.Diab Vasc Dis Res · 20165 citationsRCR 0.2
- 5 citationsRCR 0.3
- The 5:2 Diet Affects Markers of Insulin Secretion and Sensitivity in Subjects with and without Type 2 Diabetes-A Non-Randomized Controlled Trial.Int J Mol Sci · 20245 citationsRCR 0.8
- The influence of vasopressin deficiency and acute desmopressin administration on melatonin secretion in patients with central diabetes insipidus.J Endocrinol Invest · 20044 citationsRCR 0.1